When comparing outcomes of interest during treatment, there was a general trend towards higher morbidity, hospitalization, ICU admission and ER visits in the group 2; however, this did not reach statistical significance.
← all excerpts
Morbidity and mortality among patients with breast cancer receiving anticancer treatment before and during the COVID-19 pandemic: A single tertiary center experience.
1
—
—